Dr Hazel Bradley

B Pharm (Hons) (Bath), MPH, PhD (UWC)

Senior Lecturer
E: hbradley@uwc.ac.za

Hazel Bradley, is a registered pharmacist and leads the area of specialisation of Pharmaceutical Public Health within the MPH.

She was instrumental in the development of short courses and online semester modules in Rational Medicines Use, Medicines Supply Management, and Pharmaceutical Policy and Management offered to MPH students and to health practitioners as continuing education options. Hazel’s current research areas include systems approaches to investigate and improve medicines management and access; pharmaceutical human resources and district level services; pharmacovigilance; and pharmaceutical and public health education and training. She has a number of international collaborations including with the Institute of Tropical Medicine, Antwerp and Boston University; and with the East African Regional Centre of Excellence in Health Supply Chain Management, and other partnerships in Sub-Saharan Africa which link academia and pharmaceutical services.

Projects

South African higher education institutions as drivers of change for health and wellbeing

This project seeks to address the twin challenges of developing capacity for training and research in pharmaceutical public health and doctoral education, and contributing to the goal of strengthening health and pharmaceutical systems capable of sustainably addressing key threats to health.

SPaRCS Launches CHW Training Materials on Adverse Drug Reaction Reporting

Despite the important roles Community Health Workers (CHWs) play in monitoring TB and HIV treatment, they have almost no training in adverse drug reactions (ADRs) and little material is available on this topic for this level of health worker. The SPaRCS project worked collaboratively between 2020 and 2023 to develop training materials to address this gap. The materials are open source and aim to increase awareness and facilitate initiatives to increase adverse drug reaction reporting by health care workers, including community health workers.

Support to the Regional Centre of Excellence for Vaccines, Immunisation and Health Supply Management

Technical Support to the implementation of the East African Community RCE-VIHSCM

Strengthening capacity for research, education, policy support, advocacy and networking of the partners in the field of human and animal health

SOPH’s key focus with ITM has been on strengthening South-based knowledge generation based on ‘embedded country’ health policy and systems research (HPSR) and education.

Strengthening Pharmacovigilance and Regulatory Capacities in four Southern African countries (SPaRCS)

SPaRCS is a 3-year project which commenced in April 2020 funded by the European and Developing Countries Clinical Trials Partnership (EDCTP)

Launch Webinar: Responsive Dialogues For Addressing Antimicrobial Resistance And Enhancing Community Engagement

Please join the launch of the modular Responsive Dialogues Guidelines developed by ICARS in collaboration with the School of Public Health, University of the Western Cape and funded by Wellcome.

Pharmaceutical Public Health

In 2024 we will offer Pharmaceutical Policy and Management and Rational Medicines Use as online semester modules from July-November 2024. These modules may be taken as individual stand-alone modules or as part of the Master of Public Health. The Pharmaceutical Policy and Management Module will introduce participants to pharmaceutical policy and management issues within health systems. It will provide a foundation for pharmaceutical policy analysis, policy development and implementation skills at country and local levels. Selected areas include quality of medical products, pharmaceutical procurement and supply, human resources, and antimicrobials.

SPaRCS Strengthening Clinical Trials Oversight Workshop

The SPARCS Project hosted a workshop to support increased collaboration and networking between national regulatory authorities (NRAs) and national ethical committees (NECs) on the regulation of clinical trials in Southern Africa and identify priority areas for a framework for effective clinical trial oversight in the region.